These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6121871)

  • 1. L-Tyrosine enhancement of the elevation of 3,4-dihydroxyphenylacetic acid concentration in rat brain by spiperone and amfonelic acid.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1982 Feb; 34(2):117-8. PubMed ID: 6121871
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of cholinomimetic drugs in combination with amfonelic acid or spiperone on the concentration of 3,4-dihydroxyphenylacetic acid in rat brain.
    Fuller RW; Snoddy HD; Molloy BB
    Pharmacol Res Commun; 1978 Mar; 10(3):229-33. PubMed ID: 684031
    [No Abstract]   [Full Text] [Related]  

  • 3. Synergistic elevation of brain 3,4-dihydroxyphenylacetic acid concentration by methylphenidate and spiperone in control but not reserpine-pretreated rats.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1979 May; 31(5):339. PubMed ID: 37308
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of prolintane on 3,4-dihydroxyphenylacetic acid concentration in rat brain after spiperone treatment.
    Fuller RW; Snoddy HD
    Pharmacol Biochem Behav; 1979 Apr; 10(4):561-3. PubMed ID: 572552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mazindol on brain dopamine turnover in spiperone-treated rats.
    Fuller RW; Snoddy HD
    J Neural Transm; 1979; 44(1-2):13-9. PubMed ID: 438800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of pemoline, amfonelic acid and amphetamine on dopamine uptake and release in vitro and on brain 3,4-dihydroxyphenylacetic acid concentration in spiperone-treated rats.
    Fuller RW; Perry KW; Bymaster FP; Wong DT
    J Pharm Pharmacol; 1978 Mar; 30(3):197-8. PubMed ID: 24701
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effects of amantadine and amfonelic acid on dopamine metabolism in rat brain.
    Fuller RW; Snoddy HD; Perry KW
    Brain Res Bull; 1981 Feb; 6(2):141-3. PubMed ID: 7470959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flumezapine and zotepine: 5-hydroxytryptamine antagonism not involved in the lack of synergism of these antipsychotic drugs with amfonelic acid in rats.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1985 Oct; 37(10):755-6. PubMed ID: 2867152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fluoxetine pretreatment on the neurochemical changes induced by amfonelic acid combined with spiperone in rats.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1986 Oct; 38(10):776-7. PubMed ID: 2432213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pergolide elevation of MHPG sulphate concentration in rat hypothalamus blocked by spiperone and mimicked by other dopamine agonists.
    Fuller RW; Hemrick-Luecke SK; Perry KW; Toomey RE
    J Pharm Pharmacol; 1985 Apr; 37(4):268-70. PubMed ID: 2860228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen increases both spiperone-induced catalepsy and brain levels of [3H]spiperone in the rat.
    Chiodo LA; Caggiula AR; Saller CF
    Brain Res; 1979 Aug; 172(2):360-6. PubMed ID: 572736
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.
    Schmidt CJ; Gibb JW
    Eur J Pharmacol; 1985 Feb; 109(1):73-80. PubMed ID: 2581794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of L-dopa and L-tyrosine on release of free and conjugated dopamine, homovanillic acid and dihydroxyphenylacetic acid from slices of rat striatum.
    Tyce GM; Rorie DK
    Life Sci; 1985 Dec; 37(25):2439-48. PubMed ID: 4079658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of 3,4-dihydroxyphenylacetic acid concentration by L-5-hydroxytryptophan in control and fluoxetine-pretreated rats.
    Fuller RW; Perry KW
    J Pharm Pharmacol; 1981 Jun; 33(6):406-7. PubMed ID: 6115023
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum corticosterone elevation by pergolide in rats: prevention of tolerance development by spiperone.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1982 Sep; 34(9):607-8. PubMed ID: 6127394
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
    Rivest R; Marsden CA
    Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of homovanillic, dihydroxyphenylacetic acid and cyclic-adenosine-3',5'-monophosphate content in the rat caudate nucleus induced by the acute administration of an aminoacid mixture lacking tyrosine and phenylalanine.
    Biggio G; Porceddu ML; Gessa GL
    J Neurochem; 1976 Jun; 26(6):1253-5. PubMed ID: 180254
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of amfonelic acid with antipsychotic drugs on dopaminergic neurons.
    Gudelsky GA; Nwajei EE; Defife K; Nash JF
    Synapse; 1992 Dec; 12(4):304-11. PubMed ID: 1361248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of 3, 4-dihydroxyphenylacetic acid concentrations in rat brain and stimulation of prolactin secretion by fenfluramine: evidence for antagonism at dopamine receptor sites.
    Fuller RW; Perry KW; Clemens JA
    J Pharm Pharmacol; 1976 Aug; 28(8):643-4. PubMed ID: 11315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.